Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Current Assets (2017 - 2026)

AdaptHealth has reported Current Assets over the past 9 years, most recently at $728.9 million for Q4 2025.

  • For Q4 2025, Current Assets fell 3.56% year-over-year to $728.9 million; the TTM value through Dec 2025 reached $728.9 million, down 3.56%, while the annual FY2025 figure was $728.9 million, 3.56% down from the prior year.
  • Current Assets for Q4 2025 was $728.9 million at AdaptHealth, up from $724.8 million in the prior quarter.
  • Over five years, Current Assets peaked at $823.4 million in Q3 2021 and troughed at $503.5 million in Q1 2021.
  • A 5-year average of $655.7 million and a median of $652.5 million in 2023 define the central range for Current Assets.
  • Biggest five-year swings in Current Assets: soared 158.81% in 2021 and later dropped 23.26% in 2022.
  • Year by year, Current Assets stood at $670.1 million in 2021, then fell by 12.65% to $585.3 million in 2022, then rose by 10.89% to $649.0 million in 2023, then increased by 16.45% to $755.8 million in 2024, then decreased by 3.56% to $728.9 million in 2025.
  • Business Quant data shows Current Assets for AHCO at $728.9 million in Q4 2025, $724.8 million in Q3 2025, and $658.0 million in Q2 2025.